Navigation Links
Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems
Date:5/18/2011

SAN JOSE, Calif., May 18, 2011 /PRNewswire/ -- Oclaro, Inc. (NASDAQ: OCLR), a tier-one provider of optical communications and laser solutions, today announced that its 9xx nm high-power laser diode bars have been selected by Pantec Biosolutions, the leading provider of epidermal medical applications, for use in its next generation P.L.E.A.S.E.® (Precise Laser Epidermal System) platform. This cutting-edge new laser platform represents a new era in biomedical applications by enabling an easy, painless and needle-free delivery method for drugs, as well as safe tissue ablation for skin rejuvenation.

According to Pantec, the global aesthetic market, which includes tissue ablation, is expected to grow from a $4.4 billion market in 2010 to a $7.5 billion market in 2015; while the market for transdermal drug delivery is growing rapidly and is expected to be a multi-billion dollar market by 2015.  Designed for medical professionals and consumers, these new devices offer a pain-free delivery method for a variety of medical applications, such as in-vitro fertilization, vaccinations and wrinkle removal.  Oclaro worked closely with Pantec to deliver a customized quasi continuous wave (QCW) sub-assembly laser diode solution that delivered the performance and reliability needed, at a price point that will enable wide-spread adoption in the consumer space. Pantec's first Oclaro-based product, which is called the P.L.E.A.S.E.® Professional, is a tabletop system that will be used for both transdermal delivery and tissue ablation. This device will initially be sold in Europe with plans to bring the product into selected markets worldwide, starting in 2011.

"This win with Pantec is yet another example of how lasers have reached the price/performance targets that enable them to be widely used in the high-volume consumer space," said Gunnar Stolze, Worldwide Sales Direct
'/>"/>

SOURCE Oclaro, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions
2. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
3. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
4. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
5. MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital
6. BioFlorida Selects Collexis BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations
7. St. Paul Radiology Selects AMICAS
8. DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
9. Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship
10. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
11. Community Care Physicians Selects Allscripts Practice Management System for 190 Physicians in New York Capitol Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Research and ... "Global Cell Culture Market 2014-2018" report to their ... Cell culture is the in vitro growth of ... research, cell studies, and biopharmaceutical production. Cell culture is ... Cell culture instruments and cell culture consumables are necessary ...
(Date:7/24/2014)... Livermore, California (PRWEB) July 24, 2014 ... due to advances in modeling lithium-ion battery storage ... could benefit from a theoretical model created at ... Rice University that predicts how carbon components ... for energy storage emphasizes the urgent need for ...
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
(Date:7/24/2014)... 2014 Deep Research Report on Global ... and in-depth research report on Potassium Sulphate ... information, including its definition, classification, application, and industry ... the international market analysis, including China’s domestic market ... environment & economic situation analysis, the influence of ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... 2, 2011 Myriant Technologies, Inc. (Myriant), a ... chemicals, announces the addition of J. Brian Ferguson ... Ferguson, 56, is the former CEO and Chairman ... engaged in the manufacture and sale of a ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), ... vaccines against cancers and infectious diseases, announced today that ... DNA vaccine for foot-and-mouth disease administered by Inovio,s proprietary ... Dr. Niranjan Y. Sardesai, Inovio,s Sr. VP of Research ...
... sharp object has put Canadian researchers at the National Institute ... Book of World Records. Only one atom at its ... sharpest man-made object. It is made of Tungsten and ... being evaluated for its commercial potential., "We did not start ...
Cached Biology Technology:Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board 2Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease 2Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease 3Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease 4Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease 5Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease 6
(Date:7/24/2014)... Mass. (July 24, 2014) For years, researchers and ... forming nearly any cell type in the bodycould provide ... treat them. Yet progress has been hampered by the ... studies to their human counterparts, in part because human ... mouse cells. , Now Thorold Theunissen, Benjamin Powell, and ...
(Date:7/24/2014)... Africa in mid-July 2014, as the annual fire season ... areas of increased temperatures, are heavily sprinkled across the ... Congo (northeast), and Zambia (southeast). Thick gray smoke rises ... especially in the Democratic Republic of the Congo, strong ... fire season is an annual event in this region, ...
(Date:7/24/2014)... available in German . ... and respond to threats to health, and to provide ... of the mechanism underlying immunologic memory, however, has remained ... to support the hypothesis that the persistence of immune ... stem-cell-like potential. Until now, there was no conclusive evidence, ...
Breaking Biology News(10 mins):Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3
... the third most common family of epidermal growth factor ... Little is known about cancers harboring these mutations aside ... inhibitors, impairing the development of effective targeted therapies. A ... the International Association for the Study of Lung Cancer,s ...
... visualizing Earth science data from a NASA and U.S. Geological ... the ability to tease out the small events that can ... computer program is able to find patterns previously buried within ... led to seeing for the first time in satellite imagery ...
... 2013 A new study has found that tamoxifen, ... features in a mouse model of Duchenne muscular dystrophy ... long-term improvement of the symptoms in boys with DMD, ... muscle wasting, respiratory and cardiac impairments, paralysis, and premature ...
Cached Biology News:Landsat senses a disturbance in the forest 2Landsat senses a disturbance in the forest 3Landsat senses a disturbance in the forest 4Tamoxifen ameliorates symptoms of Duchenne muscular dystrophy 2
... Reticulocyte Lysate contains the cellular components necessary ... initiation, elongation and termination factors) but has ... Lysate is used primarily for the isolation ... source of endogenous globin mRNA. Untreated Lysate ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
Form: Concentrated Applications: ELISA...
Biology Products: